

Your annual health screening comes back and the numbers are not great. Fasting glucose is creeping up. Blood pressure is borderline high. Triglycerides are elevated. Your waist has been gradually expanding over the past few years. Individually, none of these readings scream emergency. Together, they form a pattern your doctor calls metabolic syndrome, and it means your risk of heart disease, stroke, and type 2 diabetes has gone up significantly.
Metabolic syndrome affects roughly one in four adults in Singapore. Managing it requires changes across multiple areas: weight, blood sugar, blood pressure, cholesterol, and physical activity. Telehealth makes this easier to coordinate, especially for people who struggle to fit frequent clinic visits into their schedules.
Metabolic syndrome is not a single disease. It is a cluster of conditions that occur together and increase your risk of cardiovascular disease, stroke, and type 2 diabetes. You are diagnosed with metabolic syndrome if you have three or more of the following five criteria:
| Risk factor | Threshold |
|---|---|
| Waist circumference | Men: above 90 cm; Women: above 80 cm (Asian-specific thresholds) |
| Triglycerides | 1.7 mmol/L or higher |
| HDL cholesterol | Men: below 1.03 mmol/L; Women: below 1.29 mmol/L |
| Blood pressure | 130/85 mmHg or higher, or on blood pressure medication |
| Fasting glucose | 5.6 mmol/L or higher, or on glucose-lowering medication |
The Asian-specific waist circumference thresholds are lower than the international ones (which are 102 cm for men and 88 cm for women). This is because Asian populations, including Singaporeans, develop metabolic complications at lower levels of abdominal fat.
Metabolic syndrome is common and often silent. Many people have it without knowing, because none of the individual components feel particularly alarming on their own. It is typically detected during routine health screenings.
The components of metabolic syndrome are tightly linked, and excess weight, particularly visceral fat (fat stored around your organs), is the thread that connects them.
Visceral fat is metabolically active. It releases inflammatory molecules and hormones that worsen insulin resistance, which raises blood sugar. Insulin resistance, in turn, drives more fat storage, creating a cycle that is difficult to break with diet and exercise alone.
This is where metabolic syndrome treatment overlaps with weight loss treatment. Losing 5-10% of your body weight can improve all five components of metabolic syndrome simultaneously. A 2019 meta-analysis in Diabetes Care found that moderate weight loss of 5-10% reduced the prevalence of metabolic syndrome by approximately 30% in participants who achieved it.
For patients whose weight loss has stalled despite lifestyle efforts, GLP-1 medications offer a way to break through. The weight loss they produce (14.9% in the STEP 1 trial with semaglutide, up to 20.9% with tirzepatide in SURMOUNT-1) is well above the 5-10% threshold needed to meaningfully improve metabolic markers.
GLP-1 receptor agonists (Ozempic, Wegovy, Mounjaro) were originally developed for type 2 diabetes, which is itself a component of metabolic syndrome. Their benefits extend across multiple metabolic syndrome markers.
This is the primary effect. By suppressing appetite in the brain and slowing gastric emptying, GLP-1 medications reduce calorie intake without the constant hunger that sabotages most diets. The weight loss is particularly effective at reducing visceral fat, which is the most metabolically harmful type. For a deeper look at how these medications work, see our GLP-1 mechanisms article.
GLP-1 medications enhance insulin secretion (only when blood sugar is elevated) and suppress glucagon, directly addressing the insulin resistance at the core of metabolic syndrome. In the STEP 2 trial, semaglutide reduced HbA1c by 1.6% in patients with type 2 diabetes and obesity, on top of the 9.6% weight loss.
The SURMOUNT-1 trial showed tirzepatide reduced triglycerides by 20-25% and modestly improved HDL cholesterol, two of the five metabolic syndrome criteria. Semaglutide trials showed triglyceride reductions of 12-15%.
Weight loss from GLP-1 medications typically produces a systolic blood pressure reduction of 4-6 mmHg. In the SELECT trial, semaglutide 2.4 mg reduced major adverse cardiovascular events by 20% in overweight and obese adults with existing cardiovascular disease.
By improving multiple metabolic syndrome components simultaneously, GLP-1 medications reduce overall cardiovascular risk. The SELECT trial was the first to demonstrate this benefit in patients without diabetes, making it directly relevant to the metabolic syndrome population.
Managing metabolic syndrome requires ongoing monitoring and frequent adjustments. This is where telehealth offers practical advantages over traditional clinic visits.
Metabolic syndrome management involves tracking multiple variables: weight, blood pressure, blood sugar, lipid levels, and medication responses. With traditional in-person care, these check-ins happen every three to six months. With telehealth, doctors can review progress more frequently through video consultations and messaging.
At Trimly, follow-up consultations are unlimited and included in the treatment plan. This means you can check in when a dose adjustment is needed, when side effects arise, or when your lab results come back, without scheduling a separate appointment or paying an extra fee.
Patients can track their own metrics at home (weight, blood pressure, blood glucose if relevant) and share them with their doctor between consultations. This gives the care team real-time data rather than a single snapshot every few months.
The SingHealth Primary Tech-Enhanced Care (PTEC) programme demonstrated this model: patients with hypertension used Bluetooth blood pressure monitors that automatically transmitted readings to their care team. Over six months, 42% of patients with previously uncontrolled hypertension saw their systolic blood pressure drop by at least 10 mmHg.
Metabolic syndrome management is long-term. If clinic visits are inconvenient, patients skip them, and gaps in care lead to worse outcomes. Telehealth removes the commute, the waiting room, and the need to take time off work. For a condition that requires years of consistent management, this convenience matters.
Discuss your metabolic health with a licensed doctor from home
Book ConsultationMedication alone is not enough. GLP-1 treatment works best when paired with lifestyle changes that target the underlying drivers of metabolic syndrome.
The most impactful dietary change for metabolic syndrome is reducing refined carbohydrates and increasing protein and fibre intake. In practical terms for Singapore:
For more detailed nutrition guidance during GLP-1 treatment, see our article on nutrition counseling for GLP-1 users.
Exercise improves insulin sensitivity independently of weight loss. The most effective combination for metabolic syndrome:
If you are currently sedentary, start with 10-minute walks after meals. Post-meal walking specifically has been shown to reduce blood sugar spikes.
Poor sleep worsens insulin resistance and increases appetite hormones. Aim for seven to eight hours per night. If you have symptoms of sleep apnoea (loud snoring, daytime sleepiness, waking up gasping), tell your doctor, since sleep apnoea is both a cause and consequence of metabolic syndrome.
See a doctor if your health screening results show borderline or elevated readings across multiple metabolic markers. Do not wait for a single number to cross a threshold. The pattern matters more than any individual reading.
You should also see a doctor if:
A doctor can assess whether GLP-1 medication is appropriate for you, or whether other interventions should come first.
Trimly is an MOH-licensed telehealth clinic in Singapore. If your metabolic syndrome includes excess weight as a contributing factor, a Trimly doctor can assess you for GLP-1 treatment during a video consultation. The assessment covers your medical history, current medications, BMI, and weight-related health conditions.
Treatment plans range from $350 to $650 per month, including the consultation, GLP-1 medication, home delivery, and unlimited follow-ups. If GLP-1 treatment is not appropriate for your situation, your doctor will explain why and discuss alternatives.
Start managing your metabolic health with expert support
Book ConsultationMetabolic syndrome is a cluster of conditions (high waist circumference, elevated triglycerides, low HDL, high blood pressure, and high fasting glucose) that together raise your risk of heart disease and type 2 diabetes. Weight loss of 5-10% can improve all five markers, and GLP-1 medications produce weight loss well beyond this threshold. Telehealth makes ongoing management more practical by enabling frequent check-ins, remote monitoring, and easy access to your doctor. If your health screening results are trending in the wrong direction across multiple markers, a consultation is the right next step.